Form 4: Bausch Health Director Boosts Share Holdings

Bausch Health Companies Inc. Director Sandra Leung acquired 3,673 common shares through Restricted Share Units as compensation, increasing her direct beneficial ownership to 33,822 shares.

Summary

• Sandra Leung, a Director of Bausch Health Companies Inc. (BHC), acquired 3,673 common shares.
• These shares were issued as Restricted Share Units (RSUs) in lieu of cash compensation for her service on the Board of Directors for the quarter ending September 30, 2025.
• Each RSU represents a contingent right to receive one common share, no par value, of the Issuer.
• Following this transaction, Ms. Leung directly beneficially owns 33,822 common shares.
• The transaction date was September 30, 2025.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged trading plan.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director's increased stake, even through compensation, generally signals alignment with shareholder interests and confidence in the company's future. It is a routine transaction, so the impact is limited.

Positives

• A director increasing their stake, even through compensation, can signal confidence in the company's future prospects.
• The use of Restricted Share Units aligns the director's financial interests with long-term shareholder value.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This specific insider transaction is a routine compensation event and does not provide broader insights into industry trends or the competitive landscape. It reflects standard corporate governance practices for director compensation.

Comparison to Industry Standards

• The issuance of Restricted Share Units as compensation for board service is a common practice across various industries, including pharmaceuticals and healthcare, aligning director incentives with shareholder interests.
• Many companies, such as Pfizer Inc. or Johnson & Johnson, utilize similar equity-based compensation structures for their non-employee directors to foster long-term alignment.

Corporate Governance

Related Party Transactions

• Sandra Leung, a Director of Bausch Health Companies Inc., received 3,673 Restricted Share Units as compensation for her service on the Board of Directors. This constitutes a related party transaction as it involves a company director.

Stakeholder Impact

• Shareholders: Potentially positive, as the director's increased equity stake aligns her interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director received shares as compensation. While it indicates alignment of interests, it does not provide new material information about the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific event.

Keywords

Bausch Health, BHC, Form 4, Insider Transaction, Director Compensation, Restricted Share Units, Corporate Governance, Share Acquisition